arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PROKIDNEY CORP.

PROK
$1.68 ▼ -0.15 (-7.97%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
24 Visible periods
15 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Neutral
auto_awesome

Analytical Summary

PROKIDNEY CORP. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth -32.1%
Op. Margin
ROIC 5.5%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$150.00K
↓ -32.1%
Net Income Profit after all expenses
$-28.42M
↓ -71.7%

Health Breakdown

Returns
58
Financial Health
1
Cash Quality
86

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 24 quarters